Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SoniVie announces enrollment completion in the REDUCED-1 pilot study with TIVUS™ Ultra-Sound Renal Denervation 2024-02-01 01:52
Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development 2024-02-01 00:00
Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit 2024-01-31 21:00
WuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland 2024-01-31 17:31
IGIN: the first innovative device for automatic glove fitting, is now launching a pre-sale 2024-01-31 17:13
21ST.BIO OPENS A MORE SUSTAINABLE AVENUE FOR INDUSTRIAL SCALE DAIRY PROTEIN PRODUCTION 2024-01-31 16:47
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development 2024-01-31 10:43
Synbio Tech's Innovative Probiotic Approach Revitalizes Gut and Vaginal Microbiota in Pregnant Women with Candidiasis 2024-01-31 09:00
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant 2024-01-31 05:46
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results 2024-01-31 05:30
Medtec China's 20th Anniversary brings together 1000+ Exhibitors and Facilitates Business Innovation in Shanghai in September 2024-01-31 00:00
The Biotech Accelerator Unicorn Program: A Unique Collaboration between CKGSB and the UC San Diego Rady School of Management 2024-01-30 22:25
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study 2024-01-30 22:00
XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery 2024-01-30 21:00
Singleron launches the AccuraSCOPE® Single Cell Transcriptome 2024-01-30 18:05
Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology 2024-01-30 16:45
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD 2024-01-30 16:32
MGI Unveils Comprehensive Expansion of Automation Product Lines for Life Science and Healthcare Research 2024-01-30 15:55
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation 2024-01-29 21:30
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma. 2024-01-29 21:08
1 99 100 101 102 103 963